Physician-scientists from Vanderbilt University Medical Center were well represented at the recent annual meeting of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and the American Physician-Scientist Association.

A selenium transport protein produced in the colon may be a novel biomarker for assessing disease severity and cancer risk in patients with inflammatory bowel disease.

The Medical Scientist Training Program has been intentional in approaching the challenges presented by COVID-19.

The protein kinase STK17A plays a novel role in epithelial cells and its loss may contribute to colorectal cancer invasion and metastasis, Vanderbilt researchers report.

A protein involved in binding cells together helps maintain the integrity of the intestinal mucosa and plays a protective role in ulcerative colitis.

Vanderbilt University has received a five-year, $2.5-million Physician Scientist Institutional Award from the Burroughs Wellcome Fund to help bolster the dwindling number of active physician-scientists in the United States.

Christopher Williams, M.D., Ph.D., associate professor of Medicine and Cancer Biology, was recently named associate dean for Vanderbilt University School of Medicine’s Physician-Scientist Education and Training Program (PSTP) and director of the Medical Science Training Program (MSTP).